Literature DB >> 11814797

2-Amino-4-[3'-hydroxyphenyl]-4-hydroxybutanoic acid; a potent inhibitor of rat and recombinant human kynureninase.

Harold A Walsh1, Pauline L Leslie, Karen C O'Shea, Nigel P Botting.   

Abstract

A novel structural analogue of kynurenine, 2-amino-4-[3'-hydroxyphenyl]-4-hydroxybutanoic acid 6, was synthesised as an inhibitor of kynureninase. The compound had a significant inhibitory effect on kynureninase from both rat and human, giving a K(i) of 100 nM. It was thus found that removal of the aryl amino group coupled with a reduction of the carbonyl group at position 7 of the alanine side chain greatly enhanced potency of the inhibitor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11814797     DOI: 10.1016/s0960-894x(01)00758-2

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

Review 1.  Kynurenines in the CNS: recent advances and new questions.

Authors:  László Vécsei; Levente Szalárdy; Ferenc Fülöp; József Toldi
Journal:  Nat Rev Drug Discov       Date:  2012-12-14       Impact factor: 84.694

Review 2.  Structure, mechanism, and substrate specificity of kynureninase.

Authors:  Robert S Phillips
Journal:  Biochim Biophys Acta       Date:  2010-12-15

Review 3.  Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.

Authors:  Ping Song; Tharmarajan Ramprasath; Huan Wang; Ming-Hui Zou
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

Review 4.  Major Developments in the Design of Inhibitors along the Kynurenine Pathway.

Authors:  Kelly R Jacobs; Gloria Castellano-Gonzalez; Gilles J Guillemin; David B Lovejoy
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

Review 5.  KYNU, a novel potential target that underpins CD44-promoted breast tumour cell invasion.

Authors:  Maryam Al-Mansoob; Ishita Gupta; Radoslaw Stefan Rusyniak; Allal Ouhtit
Journal:  J Cell Mol Med       Date:  2021-01-24       Impact factor: 5.310

6.  Small Molecule Regulators Targeting NAD+ Biosynthetic Enzymes.

Authors:  Alyson Curry; Dawanna White; Yana Cen
Journal:  Curr Med Chem       Date:  2022       Impact factor: 4.740

7.  Comparative inhibition by substrate analogues 3-methoxy- and 3-hydroxydesaminokynurenine and an improved 3 step purification of recombinant human kynureninase.

Authors:  Harold A Walsh; Karen C O'Shea; Nigel P Botting
Journal:  BMC Biochem       Date:  2003-09-24       Impact factor: 4.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.